Skip to main content
. 2018 Jan 31;33(4):415–423. doi: 10.1007/s10654-018-0360-5

Table 5.

OR with 95% CI of developing ACPA positive and negative RA for smokers compared with never-smokers, by number of years since stopping smoking and cumulative dose of smoking

ACPA positive RA
Pack years of smoking
Years since stopping smoking
0 < 10 10–20 > 20
Never smokers 730/2655 1.0 (reference)
Current smokers 146/411 1.2 (1.0–1.4) 227/325 2.5 (2.1–3.1) 382/518 2.8 (2.4–3.3)
< 10 years 114/254 1.5 (1.2–1.9) 109/149 2.7 (2.1–3.6) 185/181 4.0 (3.2–5.1)
10–20 years 92/250 1.4 (1.1–1.8) 81/188 1.7 (1.3–2.6) 63/114 2.3 (1.7–3.2)
> 20 years 133/466 1.2 (0.9–1.4) 46/158 1.2 (0.9–1.8) 23/57 1.7 (1.0–2.8)
ACPA negative RA
Pack years of smoking
Years since stopping smoking
0 < 10 10–20 > 20
Never smokers 480/2655 1.0 (reference)
Current smokers 81/411 1.2 (0.9–1.6) 89/325 1.5 (1.2–1.9) 143/518 1.5 (1.1–1.8)
< 10 years 50/254 1.2 (0.9–1.7) 46/149 1.7 (1.1–2.3) 57/181 1.6 (1.2–2.3)
10–20 years 56/250 1.3 (1.0–1.8) 37/188 1.1 (0.7–1.6) 34/114 1.5 (1.0–2.3)
> 20 years 104/466 1.2 (0.9–1.5) 22/158 0.8 (0.5–1.2) 10/57 0.9 (0.5–1.7)

Adjusted for age, gender, residential area, study, ancestry, educational level, passive smoking, alcohol consumption, and body mass index at inclusion in the study